NPI: 1942244363 · VERNON, CT 06066 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/15/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/15/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,696 | $114K |
| 2019 | 13,504 | $116K |
| 2020 | 10,454 | $74K |
| 2021 | 4,958 | $43K |
| 2022 | 994 | $5K |
| 2023 | 442 | $4K |
| 2024 | 844 | $6K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,974 | 1,197 | $103K |
| 83970 | 568 | 467 | $85K | |
| 82728 | 437 | 364 | $56K | |
| 83550 | 438 | 365 | $29K | |
| 83540 | 439 | 366 | $24K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,957 | 451 | $19K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,458 | 565 | $15K |
| 82108 | 36 | 32 | $9K | |
| 85041 | 840 | 725 | $7K | |
| 85048 | 819 | 709 | $5K | |
| A4657 | Syringe, with or without needle, each | 933 | 826 | $5K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 279 | 178 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 1,640 | 442 | $1K |
| G0008 | Administration of influenza virus vaccine | 41 | 32 | $148.65 |
| 90674 | 33 | 27 | $0.00 |